Comparison of single-port, multi-port video-assisted thoracoscopic and open lobectomy for children: a single-center experience
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Mar 2022 · 1 min read
In brief
In brief
Retrospective single-center study of 71 pediatric patients demonstrates that single-port VATS lobectomy achieves comparable outcomes to multi-port VATS while offering significant advantages over open lobectomy, including reduced blood loss, shorter drainage duration, and decreased hospital stay. Findings support SPVATS as a safe, feasible minimally invasive approach for pediatric lung resection.
Written by the GCMD Library team from the article.
Abstract
Purpose
The feasibility of single-port video-assisted thoracic surgery (SPVATS) for pediatric lobectomy has not been clearly established. We compared the feasibilities of single-port (SP), multi-port (MP) VATS and open lobectomy (OL) for surgical treatment of children with lung disease.
Methods
In this study, we retrospectively analyzed and compared data for 22,19 and 30 pediatric lung disease patients who had been subjected to SP, MP and OL, respectively. These procedures were performed between March, 2012 and August, 2020 at the Second Affiliated Hospital of Wenzhou Medical University. Perioperative clinical indicators were analyzed.
Results
Compared to OL, SP was associated with lower intraoperative blood loss (p = 0.008), lower postoperative thoracic drainage volume (p = 0.041), shorter chest drainage duration (p = 0.002) and hospital stay (p = 0.001). Operation time (p = 0.437), volume of estimated blood loss (p = 0.979), conversion rate to thoracotomy (p = 0.861), total thoracic drainage volume (p = 0.824), duration of chest tube drainage (p = 0.543), length of hospital stay (p = 0.812) and incidences of postoperative complications were comparable in MP and SP groups.
Conclusion
SPVATS is a safe and feasible approach for lobectomy in pediatrics, with comparable postoperative clinical outcomes to MPVATS and better outcomes relative to OL. However, studies with large sample sizes in multicenter should be performed to verify our findings.